We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTFB.L Regulatory News (MTFB)

  • There is currently no data for MTFB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

14 Aug 2018 16:48

RNS Number : 8015X
Motif Bio PLC
14 August 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Motif Bio plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

X

An event changing the breakdown of voting rights

 

Other (please specify)iii:

 

3. Details of person subject to the notification obligationiv

Name

Aviva plc & its subsidiaries

City and country of registered office (if applicable)

London, England

4. Full name of shareholder(s) (if different from 3.)v

Name

Registered Holder:

 

Available Upon Request 3,444*

*denotes direct interest

 

 

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reachedvi:

13/08/2018

6. Date on which issuer notified (DD/MM/YYYY):

14/08/2018

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

0.001%

0.000%

0.001%

296,660,243

Position of previous notification (if

applicable)

2.94%

0.20%

3.14%

 

        

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary SharesGB00BVVT4H71

3,444

 N/A

 0.001%

N/A

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. A

3,444

0.001%

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

 

 

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

          

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

 

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Aviva plc

 

 

 

Aviva Group Holdings Limited

 

 

 

Aviva Investors Holdings Limited

 

 

 

Aviva Investors Global Services Limited

 

 

 

 

 

 

 

Aviva plc

 

 

 

Aviva Group Holdings Limited

 

 

 

Friends Provident

International Limited

 

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

See Section 4

The number and % of voting rights held

 

The date until which the voting rights will be held

 

 

11. Additional informationxvi

This notification is prompted by a 3% to

     

 

Place of completion

Norwich, England

Date of completion

14 August 2018

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLLLFSETRISLIT
Date   Source Headline
14th Sep 201611:15 amRNSIssue of Equity
8th Sep 20167:00 amRNSRe-negotiation of the terms of the CPNs
8th Sep 20167:00 amRNSUPDATE ON REVIVE-1 PHASE 3 CLINICAL TRIAL
26th Aug 20167:00 amRNSChief Medical Officer presents at congress in USA
22nd Aug 20164:31 pmRNSDirector/PDMR Shareholding
16th Aug 20167:00 amRNSHalf-year Report
9th Aug 20165:24 pmRNSHolding(s) in Company
9th Aug 20167:00 amRNSUpdate on timing of proposed US Public Offering
5th Aug 20167:00 amRNSHolding(s) in Company
1st Aug 20162:15 pmRNSResult of General Meeting
28th Jul 20164:22 pmRNSPreliminary prospectus filed
18th Jul 20164:38 pmRNSDirector/PDMR Shareholding
13th Jul 20167:01 amRNSNotice of Intention to List on NASDAQ by Motif Bio
13th Jul 20167:01 amRNSCircular to allot shares for proposed US Offering
13th Jul 20167:00 amRNSFiles For Proposed U.S. Public Offering
1st Jul 20167:00 amRNSDirectorate Change
2nd Jun 20163:37 pmRNSResult of AGM
1st Jun 20167:00 amRNSCEO to Present at BIO 2016
24th May 20167:00 amRNSInvestor presentation
28th Apr 20167:03 amRNSRe. Amphion Innovations plc
25th Apr 20167:00 amRNSReplay for Analyst & Investor Conference Call
22nd Apr 20167:00 amRNSGrant of Options
21st Apr 20167:00 amRNSAnnual Report and Accounts 2015
20th Apr 20167:00 amRNSFinal Results
18th Apr 20167:00 amRNSResults Conference Call Details
14th Apr 20167:00 amRNSSenior Appointments
23rd Mar 20167:00 amRNSMotif Bio to present at BIO-Europe Spring
14th Mar 20167:00 amRNSAppointment of strategic adviser
2nd Mar 20167:00 amRNSFirst patient dosed in iclaprim Phase 3 trials
23rd Feb 20165:39 pmRNSHolding(s) in Company
22nd Feb 20167:00 amRNSWebcast on Combating antibiotic resistance
25th Jan 20167:00 amRNSAppointments of U.S. finance adviser and auditor
22nd Dec 20157:00 amRNSExercise of Warrants
15th Dec 20157:00 amRNSIclaprim Clinical Trial Supplies Manufactured
7th Dec 20157:00 amRNSMotif selected to present at Biotech Showcase
24th Nov 20157:00 amRNSReceipt of FDA Concurrence
11th Nov 20157:00 amRNSEuropean Agreement for Iclaprim Development
27th Oct 20157:00 amRNSSelected to Present at BIO-Europe 2015
21st Oct 20157:00 amRNSExercise of Options
16th Oct 20157:00 amRNSLeading CRO to Conduct Iclaprim Phase III Trials
13th Oct 20157:00 amRNSResults of Two Posters on Iclaprim at ID Week 2015
12th Oct 20153:59 pmRNSExercise of Options
5th Oct 20154:41 pmRNSDirectors Dealings
29th Sep 20157:01 amRNSPresentation of Two Posters on Iclaprim
23rd Sep 20153:04 pmRNSIssue of Shares for Exercised Warrants
3rd Sep 20157:00 amRNSFDA Grants Fast Track Designation for Iclaprim
2nd Sep 20157:00 amRNSParticipation at Upcoming Investor Events
2nd Sep 20157:00 amRNSAppointment of IR Adviser
27th Aug 20157:01 amRNSInterims Results for the 6 months to 30 June 2015
24th Aug 20157:00 amRNSPotent Efficacy of Iclaprim Confirmed

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.